University Department of Vascular Surgery, Heart of England NHS Foundation Trust, UK.
NHS Abdominal Aortic Aneurysm Screening Programme (NAAASP), Public Health England, UK.
Eur J Vasc Endovasc Surg. 2021 Feb;61(2):192-199. doi: 10.1016/j.ejvs.2020.09.009. Epub 2020 Oct 24.
The NHS Abdominal Aortic Aneurysm Screening Programme (NAAASP) has been implemented since 2013. Men with a large aneurysm >54 mm, either at first screen or during surveillance, are referred for intervention. The aim of the present study was to explore outcomes in these men and to see whether there was any regional variation in treatment rates and type of repair.
The study cohort included all men referred to a vascular network with a large abdominal aortic aneurysm (AAA). Basic demographic information, nurse assessment details, as well as outcome data were extracted from the national NAAASP IT system, AAA SMaRT, for analysis.
Some 3 026 men were referred for possible intervention (48% first screen, 52% surveillance). Some 448 men (13.3%) either declined (63, 2.1%), or were turned down for early intervention for various reasons (385, 12.7%). Some 8% were declined for medical reasons (true turn down rate). Men referred from surveillance were older, and more likely not to have had elective surgery within three months (16.0 vs. 11.2%; HR 1.37, 95% CI 1.07-1.75, p = .011). Turn down rates did not vary among local programmes, when surveillance men were taken into account. Some 2 624 (87%) men had planned AAA repair, with a peri-operative mortality of 1.3%. Thirty day surgical mortality was lower after EVAR: 0.4% compared with 2.1% after open repair. The method of repair remained consistent year on year, with roughly equal numbers undergoing endovascular (50%) and open surgical repair (48%); 2% unknown. There was regional variation in the proportion treated by endovascular repair: from 20% to 97%.
The turn down rate after referral for treatment with a screen detected AAA was low, but there remains considerable regional variation in the proportion undergoing endovascular repair. Procedures were undertaken with low peri-operative mortality.
英国国民保健制度(NHS)腹主动脉瘤筛查计划(NAAASP)自 2013 年开始实施。首次筛查或随访时发现直径大于 54mm 的大型腹主动脉瘤(AAA)的男性患者需要接受介入治疗。本研究旨在探讨这些男性患者的治疗结果,并观察治疗率和修复类型是否存在区域性差异。
研究队列包括所有因大型腹主动脉瘤而被转介至血管网络的男性患者。从国家 NAAASP IT 系统(AAA SMaRT)中提取基本人口统计学信息、护士评估详细信息以及结局数据进行分析。
共有 3026 名男性患者(48%为首次筛查,52%为随访)被转介进行可能的干预。有 448 名男性患者(13.3%)因各种原因拒绝(63 例,2.1%)或不适合早期介入治疗(385 例,12.7%)。8%的患者因医学原因被拒绝(真实拒绝率)。来自随访的患者年龄较大,且在三个月内更不可能接受择期手术(16.0%比 11.2%;HR 1.37,95%CI 1.07-1.75,p=0.011)。考虑到随访患者,当地计划之间的拒绝率没有差异。有 2624 名男性(87%)计划进行 AAA 修复,围手术期死亡率为 1.3%。30 天手术死亡率在 EVAR 后较低:0.4%比开放修复后 2.1%。修复方法逐年保持一致,接受血管内治疗(50%)和开放手术修复(48%)的人数大致相等;2%的患者治疗方法未知。血管内修复的比例存在区域性差异:从 20%到 97%不等。
因筛查发现的 AAA 而转介治疗的患者拒绝率较低,但接受血管内修复的比例仍存在较大的区域性差异。手术的围手术期死亡率较低。